DNA Damage and Repair Biomarkers of Immunotherapy Response

DNA-damaging agents are widely used in clinical oncology and exploit deficiencies in tumor DNA repair. Given the expanding role of immune checkpoint blockade as a therapeutic strategy, the interaction of tumor DNA damage with the immune system has recently come into focus, and it is now clear that t...

Full description

Bibliographic Details

Published in:	Cancer discovery Vol. 7; no. 7; p. 675
Main Authors:	Mouw, Kent W, Goldberg, Michael S, Konstantinopoulos, Panagiotis A, D'Andrea, Alan D
Format:	Journal Article
Language:	English
Published:	United States 01.07.2017
Subjects:	Antineoplastic Agents - immunology Antineoplastic Agents - therapeutic use Biomarkers, Tumor - genetics Biomarkers, Tumor - immunology DNA Damage - drug effects DNA Damage - immunology DNA Repair - drug effects DNA Repair - immunology Genomic Instability - drug effects Genomic Instability - immunology Humans Immunotherapy - adverse effects Neoplasms - genetics Neoplasms - immunology Neoplasms - therapy
ISSN:	2159-8290, 2159-8290
Online Access:	Get more information
Tags:	Add Tag No Tags, Be the first to tag this record!